Literature DB >> 9651411

Cost-effectiveness of care for very low birth weight infants.

J Rogowski1.   

Abstract

OBJECTIVE: Very low birth weight (VLBW)infants (those with birth weights <1500 g) account for only 1.2% of births but 46% of infant deaths. Large improvements in neonatal technology in the last 2 decades have significantly improved survival prospects for infants with low birth weights, but at a high cost. Due largely to a lack of data, the costs of medical care during the period in which infant mortality is measured (the first year of life), as well as the cost-effectiveness of that care for VLBW infants, have not been quantified. Despite this fact, public policies both toward providing insurance coverage for their care, as well as denying payment for their treatment, have either been proposed or implemented on cost-effectiveness grounds. PATIENTS: The study includes all VLBW single live births in the state of California during 1986 and 1987 that were continuously eligible (through traditional channels) for the state's Medicaid program. MAIN OUTCOME MEASURES: Treatment costs were measured for all medical care received during the first year of life, including all inpatient and outpatient care received. The cost-effectiveness of care is measured by aggregate treatment costs for all singleton VLBW liveborns divided by the number of first-year survivors.
RESULTS: Average treatment costs per first-year survivor for infants <1500 g was $93 800 (in 1987 constant dollars). Treatment costs per survivor were twice as high for infants <750 g ($273 900) as for the next highest birth weight group 750 to 999 g ($138 800) which was itself almost twice as high as for the 1000 to 1249 g group ($75 100). The gradient in cost-effectiveness with birth weight then drops off to $58 000 per survivor for infants with birth weights between 1250 and 1499 g.
CONCLUSION: Public policies aimed at improving birth outcomes by providing insurance coverage for pregnant women and children, such as the recent Medicaid expansions, can potentially be very cost-effective. Although maternal interventions such as prenatal care are relatively inexpensive, each normal birth that results instead in a VLBW birth saves $59 700 in first year medical expenses. However, cost savings attributable to increased birth weights depend on where in the birth weight distribution the increase occurs as well as the size of the birth weight increase. For infants with birth weights >750 g, significant gains can accrue from even a small shift in the birth weight distribution. A shift of 250 g at birth saves an average of $12 000 to $16 000 in first year medical costs and a shift of 500 g generates $28 000 in savings. However, there is a threshold effect on birth weight. For infants <750 g, increases in birth weight may increase medical expenditures. For instance, a shift in birth weight to the 750 to 999 g range increases costs by $29 000.

Entities:  

Mesh:

Year:  1998        PMID: 9651411     DOI: 10.1542/peds.102.1.35

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  25 in total

1.  The impact of the increasing number of multiple births on the rates of preterm birth and low birthweight: an international study.

Authors:  Béatrice Blondel; Michael D Kogan; Greg R Alexander; Nirupa Dattani; Michael S Kramer; Alison Macfarlane; Shi Wu Wen
Journal:  Am J Public Health       Date:  2002-08       Impact factor: 9.308

2.  Factors associated with high hospital resource use in a population-based study of children with orofacial clefts.

Authors:  Hilda Razzaghi; April Dawson; Scott D Grosse; Alexander C Allori; Russell S Kirby; Richard S Olney; Jane Correia; Cynthia H Cassell
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-02

3.  Factors associated with inpatient hospitalizations among patients aged 1 to 64 years with congenital heart defects, Arkansas 2006 to 2011.

Authors:  Regina M Simeone; Matthew E Oster; Charlotte A Hobbs; James M Robbins; R Thomas Collins; Margaret A Honein
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-07-14

4.  Trends in incidence and outcomes of gastroschisis in the United States: analysis of the national inpatient sample 2010-2014.

Authors:  Parth Bhatt; Anusha Lekshminarayanan; Keyur Donda; Fredrick Dapaah-Siakwan; Badal Thakkar; Sumesh Parat; Shilpi Chabra; Zeenia Billimoria
Journal:  Pediatr Surg Int       Date:  2018-07-28       Impact factor: 1.827

5.  Population-based study of hospital costs for hospitalizations of infants, children, and adults with a congenital heart defect, Arkansas 2006 to 2011.

Authors:  Regina M Simeone; Matthew E Oster; Charlotte A Hobbs; James M Robbins; R Thomas Collins; Margaret A Honein
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-06-10

6.  Hospitalizations and associated costs in a population-based study of children with Down syndrome born in Florida.

Authors:  April L Dawson; Cynthia H Cassell; Matthew E Oster; Richard S Olney; Jean Paul Tanner; Russell S Kirby; Jane Correia; Scott D Grosse
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-08-13

7.  Impaired sleep and well-being in mothers with low-birth-weight infants.

Authors:  Shih-Yu Lee; Laura P Kimble
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2009 Nov-Dec

8.  The impact of changes in preterm birth among twins on stillbirth and infant mortality in the United States.

Authors:  D Getahun; K Demissie; S W Marcella; G G Rhoads
Journal:  J Perinatol       Date:  2014-06-26       Impact factor: 2.521

9.  Cost of morbidities in very low birth weight infants.

Authors:  Tricia J Johnson; Aloka L Patel; Briana J Jegier; Janet L Engstrom; Paula P Meier
Journal:  J Pediatr       Date:  2012-08-19       Impact factor: 4.406

10.  Issues and biases in matching medicaid pregnancy episodes to vital records data: the Arkansas experience.

Authors:  Janet M Bronstein; Charles T Lomatsch; David Fletcher; Terri Wooten; Tsai Mei Lin; Richard Nugent; Curtis L Lowery
Journal:  Matern Child Health J       Date:  2008-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.